查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830861

2025年全球快速药物微生物学检测市场报告

Pharmaceutical Rapid Microbiology Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，药品快速微生物检测市场规模迅速扩张，从2024年的10.1亿美元成长到2025年的11.9亿美元，复合年增长率达17.8%。这段历史性时期的成长动力源自于对可靠微生物检测需求的日益增长、对病人安全的日益重视、药品生产过程日益复杂、对污染风险的日益担忧，以及在产品放行过程中微生物检测应用的日益普及。

预计未来几年，医药快速微生物检测市场规模将快速成长，到2029年将达到22.6亿美元，复合年增长率为17.4%。预测期内的成长可归因于对快速获得结果的需求不断增长、个人化医疗的普及、社会对药品安全的日益关注、生技药品和无菌药品生产的扩大以及先进品管措施的实施力度不断加大。预计这段时期的主要趋势包括分子诊断技术的进步、自动化整合、技术主导的即时数据分析、生物感测器的创新以及基于人工智慧的分析技术的进步。

快速药物微生物检测是一种先进的方法，用于检测和测量药物和製程中的微生物，其速度远快于传统的培养为基础的方法，通常在数小时内而非数天内即可提供结果。这些快速方法有助于加快决策速度，减少产品放行延迟，并透过降低微生物污染风险来加强品管。

药品快速微生物检测的主要产品类型包括仪器、试剂和套件以及配件。仪器是专门的实验室工具，旨在提供准确、高效和标准化的微生物检测，以确保药品的安全和品质。所采用的技术多种多样，包括聚合酵素链锁反应(PCR)、三磷酸Adenosine(ATP) 生物发光、流式细胞技术、酵素结合免疫吸附检测法(ELISA)、层析法、生物感测器和生物检测以及电阻微生物学。这些方法用于检测各种微生物，包括细菌、真菌（酵母和霉菌）、病毒、霉浆菌和内毒素。应用包括原料检测、进程内检测、微生物限量检测、微生物附着量评估、製程用水检测、环境监测和无菌测试。主要最终用户包括製药和生物技术公司、契约製造组织 (CMO)、医院和诊断实验室以及研究和学术机构。

2025年春季美国关税的突然上调及其引发的贸易摩擦正对製药公司造成严重衝击。高利润率的学名药製造商尤其容易受到影响，一些公司甚至缩减了低收益药品的生产。由于关税导致的专用试剂短缺，生物技术公司正面临临床试验延期。为此，该产业正在印度和欧洲扩大原料药的生产，增加库存，并积极游说获得基本药物的贸易豁免。

《製药快速微生物检测市场》研究报告是商业研究公司最新报告系列的一部分，该系列提供製药快速微生物检测市场统计数据，例如全球市场规模、区域份额、竞争对手的市场份额、详细的製药快速微生物检测市场细分、市场趋势以及製药快速微生物检测行业的商机。本《製药快速微生物检测市场》研究报告对产业现状和未来趋势进行了详细分析，为您提供所需的一切观点。

个人化医疗日益受到重视，预计将在未来几年推动药物快速微生物学检测市场的扩张。个人化医疗根据个人的基因特征、生活方式和环境因素来客製化医疗保健决策和治疗。由于对更安全、更有效的标靶治疗的需求不断增长，这种方法变得越来越突出，这些治疗可以最大限度地减少治疗选择中的试验。快速药物微生物学检测在支持个人化医疗方面发挥关键作用，它能够快速检测微生物污染物，确保客製化治疗方法的无菌性和安全性。例如，2024 年 2 月，美国非营利组织个人化医疗联盟报告称，FDA 在 2023 年核准了16 种针对罕见疾病患者的新型个人化治疗方法，而 2022 年则批准了 6 种。因此，对个人化医疗的日益关注正在推动对快速药物微生物学检测的需求。

製药快速微生物检测市场的公司也在寻求创新解决方案，例如三Adenosine腺苷 (ATP) 生物发光，以加速产品发布，同时确保法规遵循。 ATP 生物发光是一种快速检测技术，它透过基于萤光素酶的光反应测量 ATP 水平来检测活微生物，光强度与药物、医疗设备和相关产品的微生物污染水平相对应。例如，2025 年 3 月，美国健康公司 Nelson Labs LLC 宣布推出快速无菌测试服务。这种新方法提供了更快的检测、自动化分析和高通量测试能力。透过在不影响合规性的前提下显着缩短测试时间，该服务支援各种製药和医疗设备产品，从而实现更快、更可靠的产品发布。

2025年1月，总部位于英国的医疗设备和药品检测服务提供者Cormica Limited收购了Focus Laboratories, Inc.，收购金额未揭露。此次收购巩固了Cormica在实验室检测领域的地位，并扩展了其产品组合，为製药和医疗保健客户提供先进的检测解决方案。 Focus Laboratories, Inc.是一家总部位于美国的製药公司，专注于药品的快速微生物检测。

医药快速微生物检测市场由提供微生物污染检测、鑑定、计数和无菌检测等服务的公司所获得的收益组成。市场价值还包括服务供应商销售的或包含在其服务产品中的相关产品的价值。医药快速微生物检测市场还包括快速无菌检测套组、内毒素检测套件、微生物附着量检测系统、环境监测工具和分子检测套组的销售。该市场的价值是“出厂价”，即产品製造商或创造者销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的产品价值。该市场中的产品价值还包括产品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球製药快速微生物学检测：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球快速药物微生物学检测市场：成长率分析
  • 全球医药快速微生物检测市场表现：规模与成长，2019-2024
  • 全球製药快速微生物检测市场预测：规模与成长，2024-2029年，2034年
  • 全球快速药物微生物学检测：总目标市场（TAM）

第六章 市场细分

  • 全球医药快速微生物检测市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 装置
  • 试剂和套件
  • 配件
  • 全球医药快速微生物检测市场：按技术类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素链锁反应（PCR）
  • Adenosine腺苷（ATP）生物发光
  • 流式细胞技术
  • 酵素免疫分析法（ELISA）
  • 层析法
  • 生物感测器和生物检测
  • 电阻微生物学
  • 其他类型的技术
  • 全球医药快速微生物检测市场：2019-2024年、2024-2029年、2034年
  • 细菌
  • 真菌（酵母和霉菌）
  • 病毒
  • 霉浆菌
  • 内毒素
  • 全球医药快速微生物检测市场：应用、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 原料检测
  • 进程内测试
  • 微生物极限测试
  • 微生物附着量评估
  • 製程用水测试
  • 环境监测
  • 无菌测试
  • 全球医药快速微生物检测市场：按最终用户、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 製药和生物技术公司
  • 契约製造组织（CMO）
  • 医院和诊断实验室
  • 研究和学术机构
  • 全球医药快速微生物检测市场：依仪器类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • Adenosine腺苷（ATP）生物发光仪
  • 流式细胞仪
  • 聚合酵素链锁反应(PCR)热迴圈仪或即时聚合酵素链锁反应(PCR) 系统
  • 自动化微生物检测系统
  • 快速免疫检测装置
  • 全球医药快速微生物检测市场：按试剂和套件（按类型）细分，实际和预测，2019-2024 年、2024-2029 年、2034 年
  • Adenosine腺苷（ATP）检测套件
  • 聚合酵素链锁反应(PCR) 试剂
  • 酵素免疫分析法(ELISA)套件
  • 微生物培养基套件
  • 萤光染色试剂套件
  • 全球医药快速微生物检测市场：依附件（类型）细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 微孔盘或试管
  • 移液管和吸头
  • 过滤器和薄膜
  • 样本采集拭子

第七章 区域和国家分析

  • 全球医药快速微生物检测市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球医药快速微生物检测市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 製药快速微生物检测市场：竞争格局
  • 製药快速微生物学检测市场：公司简介
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • SGS SA Overview, Products and Services, Strategy and Financial Analysis
    • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
    • Charles River Laboratories International Inc Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • ALS Limited
  • WESSLING GmbH
  • Nelson Labs LLC
  • Labor LS SE & Co. KG
  • GBA Pharma GmbH
  • ANACON LABORATORIES PRIVATE LIMITED
  • Vimta Labs Limited
  • Pacific Biolabs Inc.
  • Wickham Laboratories
  • Microchem Laboratory Inc.
  • Infinity Laboratories Private Limited
  • Ghaziabad Testing Laboratories Private Limited
  • Medistri SA
  • PREWEL LABS PRIVATE LIMITED
  • TUV SUD SOUTH ASIA PRIVATE LIMITED

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年製药快速微生物检测市场：提供新机会的国家
  • 2029年製药快速微生物检测市场：细分市场带来新机会
  • 2029年製药快速微生物检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r37852

Pharmaceutical rapid microbiology testing refers to advanced methods that detect and measure microorganisms in pharmaceutical products and processes much faster than traditional culture-based techniques, often providing results within hours instead of days. These rapid methods strengthen quality control by supporting faster decision-making, reducing product release delays, and lowering the risk of microbial contamination.

The main product categories in pharmaceutical rapid microbiology testing include instruments, reagents and kits, and accessories. Instruments are specialized laboratory tools designed to deliver accurate, efficient, and standardized microbiological testing to ensure pharmaceutical product safety and quality. A range of technologies is employed, including polymerase chain reaction (PCR), adenosine triphosphate (ATP) bioluminescence, flow cytometry, enzyme-linked immunosorbent assay (ELISA), chromatography, biosensors and bioassays, impedance microbiology, and others. These methods are used to test various microorganisms, such as bacteria, fungi (yeast and mold), viruses, mycoplasma, and endotoxins. Applications include raw material testing, in-process testing, microbial limit testing, bioburden assessment, process water testing, environmental monitoring, and sterility testing. The primary end users are pharmaceutical and biotechnology companies, contract manufacturing organizations (CMOs), hospitals and diagnostic laboratories, and research and academic institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The pharmaceutical rapid microbiology testing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical rapid microbiology testing market statistics, including pharmaceutical rapid microbiology testing industry global market size, regional shares, competitors with a pharmaceutical rapid microbiology testing market share, detailed pharmaceutical rapid microbiology testing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical rapid microbiology testing industry. This pharmaceutical rapid microbiology testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical rapid microbiology testing market size has grown rapidly in recent years. It will grow from $1.01 billion in 2024 to $1.19 billion in 2025 at a compound annual growth rate (CAGR) of 17.8%. The growth during the historic period can be attributed to the rising need for reliable microbial detection, an increasing focus on patient safety, the growing complexity of pharmaceutical manufacturing, heightened concerns over contamination risks, and the expanded adoption of microbiology testing in product release processes.

The pharmaceutical rapid microbiology testing market size is expected to see rapid growth in the next few years. It will grow to $2.26 billion in 2029 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to the rising demand for faster results, increasing adoption of personalized medicine, growing public concerns about pharmaceutical safety, expanding production of biologics and sterile drugs, and greater implementation of advanced quality control measures. Key trends expected during this period include advancements in molecular diagnostics, the integration of automation, technology-driven real-time data analysis, innovations in biosensors, and progress in artificial intelligence-based analytics.

The growing emphasis on personalized medicine is expected to drive the expansion of the pharmaceutical rapid microbiology testing market in the coming years. Personalized medicine tailors healthcare decisions and treatments to an individual's genetic profile, lifestyle, and environmental factors. This approach is becoming more prominent due to the rising demand for safer, more effective, and targeted therapies that minimize trial-and-error in treatment selection. Pharmaceutical rapid microbiology testing plays a critical role in supporting personalized medicine by enabling faster detection of microbial contaminants, thereby ensuring the sterility and safety of customized therapies. For instance, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, compared with six in 2022. Therefore, the growing focus on personalized medicine is fueling the demand for pharmaceutical rapid microbiology testing.

Companies in the pharmaceutical rapid microbiology testing market are also advancing innovative solutions such as adenosine triphosphate (ATP) bioluminescence to accelerate product release while ensuring regulatory compliance. ATP bioluminescence is a rapid testing technique that detects live microorganisms by measuring ATP levels through a luciferase-based light reaction, with light intensity corresponding to microbial contamination levels in pharmaceuticals, medical devices, and related products. For example, in March 2025, Nelson Labs LLC, a US-based health company, introduced a rapid-method sterility testing service. This new approach provides faster detection, automated analysis, and high-throughput testing capabilities. By significantly reducing testing times without compromising compliance, the service supports a wide range of pharmaceutical and medical device products, enabling quicker and more reliable product release.

In January 2025, Cormica Ltd., a UK-based provider of medical device and pharmaceutical testing services, acquired Focus Laboratories Inc. for an undisclosed amount. The acquisition strengthens Cormica's position in the laboratory testing sector and expands its portfolio with advanced testing solutions for pharmaceutical and healthcare clients. Focus Laboratories Inc., a US-based pharmaceutical company, specializes in rapid microbiology testing for pharmaceuticals.

Major players in the pharmaceutical rapid microbiology testing market are Merck KGaA, Becton, Dickinson and Company, SGS SA, Eurofins Scientific SE, Charles River Laboratories International Inc, ALS Limited, WESSLING GmbH, Nelson Labs LLC, Labor LS SE & Co. KG, GBA Pharma GmbH, ANACON LABORATORIES PRIVATE LIMITED, Vimta Labs Limited, Pacific Biolabs Inc., Wickham Laboratories, Microchem Laboratory Inc., Infinity Laboratories Private Limited, Ghaziabad Testing Laboratories Private Limited, Medistri SA, PREWEL LABS PRIVATE LIMITED, TUV SUD SOUTH ASIA PRIVATE LIMITED.

North America was the largest region in the pharmaceutical rapid microbiology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharmaceutical rapid microbiology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharmaceutical rapid microbiology testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical rapid microbiology testing market consists of revenues earned by entities providing services such as microbial contamination detection, identification and enumeration, and sterility testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical rapid microbiology testing market also includes sales of rapid sterility testing kits, endotoxin detection kits, bioburden testing systems, environmental monitoring tools and molecular testing kits. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Rapid Microbiology Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical rapid microbiology testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical rapid microbiology testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical rapid microbiology testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Instruments; Reagents And Kits; Accessories
  • 2) By Technology Type: Polymerase Chain Reaction (PCR); Adenosine Triphosphate (ATP) Bioluminescence; Flow Cytometry; Enzyme-Linked Immunosorbent Assay (ELISA)Chromatography; Biosensors And Bioassays; Impedance Microbiology; Other Technology Types
  • 3) By Microorganism Type Tested: Bacteria; Fungi (Yeast And Mold); Viruses; Mycoplasma; Endotoxins
  • 4) By Application: Raw Material Testing; In-Process Testing; Microbial Limit Testing; Bioburden Assessment; Process Water Testing; Environment Monitoring; Sterility Testing
  • 5) By End-User: Pharmaceutical And Biotechnology Companies; Contract Manufacturing Organizations (CMOs); Hospitals And Diagnostic Laboratories; Research And Academic Institutes
  • Subsegments:
  • 1) By Instruments: Adenosine Triphosphate (ATP) Bioluminometer; Flow Cytometer; Polymerase Chain Reaction (PCR) Thermocycler Or Real-Time Polymerase Chain Reaction (PCR) System; Automated Microbial Detection Systems; Rapid Immunoassay Analyzers
  • 2) By Reagents And Kits: Adenosine Triphosphate (ATP) Detection Kits; Polymerase Chain Reaction (PCR) Reagents; Enzyme-Linked Immunosorbent Assay (ELISA) Kits; Microbial Culture Media Kits; Fluorescent Staining Kits
  • 3) By Accessories: Microplates Or Test Tubes; Pipettes And Tips; Filters And Membranes; Sample Collection Swabs
  • Companies Mentioned: Merck KGaA; Becton, Dickinson and Company; SGS SA; Eurofins Scientific SE; Charles River Laboratories International Inc; ALS Limited; WESSLING GmbH; Nelson Labs LLC; Labor LS SE & Co. KG; GBA Pharma GmbH; ANACON LABORATORIES PRIVATE LIMITED; Vimta Labs Limited; Pacific Biolabs Inc.; Wickham Laboratories; Microchem Laboratory Inc.; Infinity Laboratories Private Limited; Ghaziabad Testing Laboratories Private Limited; Medistri SA; PREWEL LABS PRIVATE LIMITED; TUV SUD SOUTH ASIA PRIVATE LIMITED
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Rapid Microbiology Testing Market Characteristics

3. Pharmaceutical Rapid Microbiology Testing Market Trends And Strategies

4. Pharmaceutical Rapid Microbiology Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Pharmaceutical Rapid Microbiology Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Pharmaceutical Rapid Microbiology Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Pharmaceutical Rapid Microbiology Testing Market Growth Rate Analysis
  • 5.4. Global Pharmaceutical Rapid Microbiology Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Pharmaceutical Rapid Microbiology Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Pharmaceutical Rapid Microbiology Testing Total Addressable Market (TAM)

6. Pharmaceutical Rapid Microbiology Testing Market Segmentation

  • 6.1. Global Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Reagents And Kits
  • Accessories
  • 6.2. Global Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • Adenosine Triphosphate (ATP) Bioluminescence
  • Flow Cytometry
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Chromatography
  • Biosensors And Bioassays
  • Impedance Microbiology
  • Other Technology Types
  • 6.3. Global Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bacteria
  • Fungi (Yeast And Mold)
  • Viruses
  • Mycoplasma
  • Endotoxins
  • 6.4. Global Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Raw Material Testing
  • In-Process Testing
  • Microbial Limit Testing
  • Bioburden Assessment
  • Process Water Testing
  • Environment Monitoring
  • Sterility Testing
  • 6.5. Global Pharmaceutical Rapid Microbiology Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Contract Manufacturing Organizations (CMOs)
  • Hospitals And Diagnostic Laboratories
  • Research And Academic Institutes
  • 6.6. Global Pharmaceutical Rapid Microbiology Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adenosine Triphosphate (ATP) Bioluminometer
  • Flow Cytometer
  • Polymerase Chain Reaction (PCR) Thermocycler Or Real-Time Polymerase Chain Reaction (PCR) System
  • Automated Microbial Detection Systems
  • Rapid Immunoassay Analyzers
  • 6.7. Global Pharmaceutical Rapid Microbiology Testing Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adenosine Triphosphate (ATP) Detection Kits
  • Polymerase Chain Reaction (PCR) Reagents
  • Enzyme-Linked Immunosorbent Assay (ELISA) Kits
  • Microbial Culture Media Kits
  • Fluorescent Staining Kits
  • 6.8. Global Pharmaceutical Rapid Microbiology Testing Market, Sub-Segmentation Of Accessories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microplates Or Test Tubes
  • Pipettes And Tips
  • Filters And Membranes
  • Sample Collection Swabs

7. Pharmaceutical Rapid Microbiology Testing Market Regional And Country Analysis

  • 7.1. Global Pharmaceutical Rapid Microbiology Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Pharmaceutical Rapid Microbiology Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Rapid Microbiology Testing Market

  • 8.1. Asia-Pacific Pharmaceutical Rapid Microbiology Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Rapid Microbiology Testing Market

  • 9.1. China Pharmaceutical Rapid Microbiology Testing Market Overview
  • 9.2. China Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Rapid Microbiology Testing Market

  • 10.1. India Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Rapid Microbiology Testing Market

  • 11.1. Japan Pharmaceutical Rapid Microbiology Testing Market Overview
  • 11.2. Japan Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Rapid Microbiology Testing Market

  • 12.1. Australia Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Rapid Microbiology Testing Market

  • 13.1. Indonesia Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Rapid Microbiology Testing Market

  • 14.1. South Korea Pharmaceutical Rapid Microbiology Testing Market Overview
  • 14.2. South Korea Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Rapid Microbiology Testing Market

  • 15.1. Western Europe Pharmaceutical Rapid Microbiology Testing Market Overview
  • 15.2. Western Europe Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Rapid Microbiology Testing Market

  • 16.1. UK Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Rapid Microbiology Testing Market

  • 17.1. Germany Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Rapid Microbiology Testing Market

  • 18.1. France Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Rapid Microbiology Testing Market

  • 19.1. Italy Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Rapid Microbiology Testing Market

  • 20.1. Spain Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Rapid Microbiology Testing Market

  • 21.1. Eastern Europe Pharmaceutical Rapid Microbiology Testing Market Overview
  • 21.2. Eastern Europe Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Rapid Microbiology Testing Market

  • 22.1. Russia Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Rapid Microbiology Testing Market

  • 23.1. North America Pharmaceutical Rapid Microbiology Testing Market Overview
  • 23.2. North America Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Rapid Microbiology Testing Market

  • 24.1. USA Pharmaceutical Rapid Microbiology Testing Market Overview
  • 24.2. USA Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Rapid Microbiology Testing Market

  • 25.1. Canada Pharmaceutical Rapid Microbiology Testing Market Overview
  • 25.2. Canada Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Rapid Microbiology Testing Market

  • 26.1. South America Pharmaceutical Rapid Microbiology Testing Market Overview
  • 26.2. South America Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Rapid Microbiology Testing Market

  • 27.1. Brazil Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Rapid Microbiology Testing Market

  • 28.1. Middle East Pharmaceutical Rapid Microbiology Testing Market Overview
  • 28.2. Middle East Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Rapid Microbiology Testing Market

  • 29.1. Africa Pharmaceutical Rapid Microbiology Testing Market Overview
  • 29.2. Africa Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Rapid Microbiology Testing Market Competitive Landscape And Company Profiles

  • 30.1. Pharmaceutical Rapid Microbiology Testing Market Competitive Landscape
  • 30.2. Pharmaceutical Rapid Microbiology Testing Market Company Profiles
    • 30.2.1. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. SGS SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Charles River Laboratories International Inc Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Rapid Microbiology Testing Market Other Major And Innovative Companies

  • 31.1. ALS Limited
  • 31.2. WESSLING GmbH
  • 31.3. Nelson Labs LLC
  • 31.4. Labor LS SE & Co. KG
  • 31.5. GBA Pharma GmbH
  • 31.6. ANACON LABORATORIES PRIVATE LIMITED
  • 31.7. Vimta Labs Limited
  • 31.8. Pacific Biolabs Inc.
  • 31.9. Wickham Laboratories
  • 31.10. Microchem Laboratory Inc.
  • 31.11. Infinity Laboratories Private Limited
  • 31.12. Ghaziabad Testing Laboratories Private Limited
  • 31.13. Medistri SA
  • 31.14. PREWEL LABS PRIVATE LIMITED
  • 31.15. TUV SUD SOUTH ASIA PRIVATE LIMITED

32. Global Pharmaceutical Rapid Microbiology Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Rapid Microbiology Testing Market

34. Recent Developments In The Pharmaceutical Rapid Microbiology Testing Market

35. Pharmaceutical Rapid Microbiology Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Pharmaceutical Rapid Microbiology Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Pharmaceutical Rapid Microbiology Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Pharmaceutical Rapid Microbiology Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer